Follow
Suhad Ali
Title
Cited by
Cited by
Year
Expression of prolactin and its receptor in human lymphoid cells.
I Pellegrini, JJ Lebrun, S Ali, PA Kelly
Molecular Endocrinology 6 (7), 1023-1031, 1992
3721992
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells
JM Boutin, M Edery, M Shirota, C Jolicoeur, L Lesueur, S Ali, D Gould, ...
Molecular Endocrinology 3 (9), 1455-1461, 1989
3601989
Expression of two forms of prolactin receptor in rat ovary and liver
M Shirota, D Banville, S Ali, C Jolicoeur, JM Boutin, M Edery, J Djiane, ...
Molecular Endocrinology 4 (8), 1136-1143, 1990
3021990
Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription.
L Lesueur, M Edery, S Ali, J Paly, PA Kelly, J Djiane
Proceedings of the National Academy of Sciences 88 (3), 824-828, 1991
2701991
Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2.
JJ Lebrun, S Ali, L Sofer, A Ullrich, PA Kelly
Journal of Biological Chemistry 269 (19), 14021-14026, 1994
2611994
Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP
H Valderrama-Carvajal, E Cocolakis, A Lacerte, EH Lee, G Krystal, S Ali, ...
Nature cell biology 4 (12), 963-969, 2002
2602002
A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor.
S Ali, I Pellegrini, PA Kelly
Journal of Biological Chemistry 266 (30), 20110-20117, 1991
2341991
Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction
JJ Lebrun, S Ali, A Ullrich, PA Kelly
Journal of Biological Chemistry 270 (18), 10664-10670, 1995
2041995
A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo
H Jallal, ML Valentino, G Chen, F Boschelli, S Ali, SA Rabbani
Cancer research 67 (4), 1580-1588, 2007
1982007
PTP1D is a positive regulator of the prolactin signal leading to beta‐casein promoter activation.
S Ali, Z Chen, JJ Lebrun, W Vogel, A Kharitonenkov, PA Kelly, A Ullrich
The EMBO journal 15 (1), 135-142, 1996
1671996
The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin
E Cocolakis, S Lemay, S Ali, JJ Lebrun
Journal of Biological Chemistry 276 (21), 18430-18436, 2001
1602001
Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells
Z Nouhi, N Chughtai, S Hartley, E Cocolakis, JJ Lebrun, S Ali
Cancer research 66 (3), 1824-1832, 2006
1502006
A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.
JJ Lebrun, S Ali, V Goffin, A Ullrich, PA Kelly
Proceedings of the National Academy of Sciences 92 (9), 4031-4035, 1995
1491995
Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion
M Dai, AA Al-Odaini, N Fils-Aimé, MA Villatoro, J Guo, A Arakelian, ...
Breast cancer research 15, 1-14, 2013
1222013
SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor
S Ali, Z Nouhi, N Chughtai, S Ali
Journal of Biological Chemistry 278 (52), 52021-52031, 2003
1152003
Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the β-casein gene promoter in mammary cells
N Chughtai, S Schimchowitsch, JJ Lebrun, S Ali
Journal of Biological Chemistry 277 (34), 31107-31114, 2002
1152002
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling
P Minoo, MM Zadeh, R Rottapel, JJ Lebrun, S Ali
Blood 103 (4), 1398-1407, 2004
1032004
Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction
A Kharitonenkov, J Schnekenburger, Z Chen, P Knyazev, S Ali, E Zwick, ...
Journal of Biological Chemistry 270 (49), 29189-29193, 1995
991995
Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways
S Ali, S Ali
Journal of Biological Chemistry 273 (13), 7709-7716, 1998
911998
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
J Tian, FA Raffa, M Dai, A Moamer, B Khadang, IY Hachim, K Bakdounes, ...
British journal of cancer 119 (12), 1495-1507, 2018
902018
The system can't perform the operation now. Try again later.
Articles 1–20